China represents a strategic priority market for many companies and investors in today’s evolving life sciences industry. Featuring the unique insights of our full-service legal team in China, this site contains valuable resources to assist clients in navigating the legal complexities of market conditions and industry trends within the region. Learn more.
In a Law360 article, health care partner Margaux Hall (Washington, D.C.) examines how biopharmaceutical manufacturers and investors should approach commercialization of emerging therapies in light of legal and regulatory uncertainty as the Biden administration rolls out its agenda for ...
The 2021 edition of Chambers Global acknowledged Ropes & Gray as a leading international law firm with five global-wide rankings for banking & finance, corporate investigations/anti-corruption, investment funds: private equity fund formation, life sciences and ...
Health care partners Mark Barnes and David Peloquin (both of Boston) will present at The Feinstein Institutes for Medical Research at Northwell Health virtual conference “Driving Responsible Conduct of Research During a Pandemic” on April 15. David and ...
